Pulmonary Disorders During Exercise in Patients With Obstructive Sleep Apnea
Exercised-Induced Bronchoconstriction in Patients With Severe Obstructive Sleep Apnea
1 other identifier
interventional
100
1 country
1
Brief Summary
Purposes:
- 1.To investigate whether patients with severe obstructive sleep apnea syndrome (OSAS) are at higher risk for exercised-induced bronchoconstriction (EIB) due to baseline airway inflammation compared with age, gender, and body mass index (BMI)-matched controls.
- 2.To investigate the effect of 3-month continuous positive airway pressure (CPAP) therapy on EIB for patients with severe OSAS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 8, 2009
CompletedFirst Posted
Study publicly available on registry
June 10, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedJune 10, 2009
June 1, 2009
1 year
June 8, 2009
June 9, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of changed forced expiratory volume in 1 second. (to determine if an exercise-induced bronchoconstriction attacked)
3 month
Secondary Outcomes (1)
Percentage of different inflammatory cells in induced sputum. (to determine to severity of baseline airway inflammation)
3 month
Interventions
CPAP of optimal pressure used during sleep for 3 months
Eligibility Criteria
You may qualify if:
- Age ranged 18-65 y/o
- Severe OSA (AHI≧30/hr)
- BMI\<35 kg/m2
You may not qualify if:
- Clinical asthma
- Chronic lung disease (FEV1\<70% predicted or FEV1/FVC\<70%)
- Exercise contraindication:
- Stroke or heart attack in last 3 months
- Major cardiovascular disease
- Unstable angina
- Unable to perform cycle ergometry due to musculoskeletal problems
- Respiratory tract infection in the past 2 weeks
- Inability to perform acceptable-quality spirometry
- Refuse to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liying Wang, Ph.D.
School and Graduate Institute of Physical Therapy, National Taiwan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 8, 2009
First Posted
June 10, 2009
Study Start
April 1, 2009
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
June 10, 2009
Record last verified: 2009-06